Humacyte sees success in dual emergency-engineered tissue trials
The two studies of the company’s engineered vascular tissue saw success with casualties in Ukraine and the US.
22 November 2024
22 November 2024
The two studies of the company’s engineered vascular tissue saw success with casualties in Ukraine and the US.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.